Benjamin Stefi V, Jégouzo Sabine A F, Lieng Chloe, Daniels Connor, Coispeau Marine, Lau Rikin J, Kim Suyeon, Metaxa Yasmine, Philpott James, Li Tiannuo, Dai Chao, Wang Xin, Newby Maddy L, Pier Gerald B, Crispin Max, Clements Abigail, Taylor Maureen E, Drickamer Kurt
Department of Life Sciences, Imperial College London, London, United Kingdom.
School of Biological Sciences, University of Southampton, United Kingdom.
J Biol Chem. 2024 Nov;300(11):107869. doi: 10.1016/j.jbc.2024.107869. Epub 2024 Oct 9.
A human lectin array has been developed to probe the interactions of innate immune receptors with pathogenic and commensal microorganisms. Following the successful introduction of a lectin array containing all of the cow C-type carbohydrate-recognition domains (CRDs), a human array described here contains the C-type CRDs as well as CRDs from other classes of sugar-binding receptors, including galectins, siglecs, R-type CRDs, ficolins, intelectins, and chitinase-like lectins. The array is constructed with CRDs modified with single-site biotin tags, ensuring that the sugar-binding sites in CRDs are displayed on a streptavidin-coated surface in a defined orientation and are accessible to the surfaces of microbes. A common approach used for expression and display of CRDs from all of the different structural categories of glycan-binding receptors allows comparisons across lectin families. In addition to previously documented protocols for binding of fluorescently labeled bacteria, methods have been developed for detecting unlabeled bacteria bound to the array by counter-staining with DNA-binding dye. Screening has also been undertaken with viral glycoproteins and bacterial and fungal polysaccharides. The array provides an unbiased screen for sugar ligands that interact with receptors and many show binding not anticipated from earlier studies. For example, some of the galectins bind with high affinity to bacterial glycans that lack lactose or N-acetyllactosamine. The results demonstrate the utility of the human lectin array for providing a unique overview of the interactions of multiple classes of glycan-binding proteins in the innate immune system with different types of microorganisms.
一种人类凝集素阵列已被开发出来,用于探究天然免疫受体与致病微生物和共生微生物之间的相互作用。在成功引入包含所有牛C型碳水化合物识别结构域(CRD)的凝集素阵列之后,此处描述的人类阵列包含C型CRD以及来自其他糖类结合受体类别的CRD,包括半乳糖凝集素、唾液酸结合凝集素、R型CRD、纤维胶凝蛋白、肝凝集素和几丁质酶样凝集素。该阵列由用单位点生物素标签修饰的CRD构建而成,确保CRD中的糖结合位点以确定的方向展示在链霉亲和素包被的表面上,并且可被微生物表面接触。一种用于表达和展示来自所有不同结构类别的聚糖结合受体的CRD的通用方法允许跨凝集素家族进行比较。除了先前记录的用于结合荧光标记细菌的方案外,还开发了通过用DNA结合染料进行复染来检测与阵列结合的未标记细菌的方法。还使用病毒糖蛋白以及细菌和真菌多糖进行了筛选。该阵列提供了对与受体相互作用的糖配体的无偏筛选,许多结果显示出与早期研究预期不同的结合。例如,一些半乳糖凝集素与缺乏乳糖或N-乙酰乳糖胺的细菌聚糖具有高亲和力结合。结果证明了人类凝集素阵列在提供天然免疫系统中多类聚糖结合蛋白与不同类型微生物相互作用的独特概述方面的实用性。